SA
CGABL logo
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061(CGABL)
Closing price · checked 4:07 PM ETAbout this dataData status
$14.68▲0.27 (1.87%)
After Hours:$14.40-0.28 (-1.91%)· 4:07 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →
CGABL logo

CGABL Common Stock Issued

Latest reported$0.00
CGABL Common Stock Issued ($0.00 → $0.00)
High-resolution chart · PNG

What is common stock issued?

Cash received from issuing common stock.

CGABL common stock issued history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Common Stock Issued — Annual fiscal periods (USD)
Period endingCommon Stock Issued (USD)Change
0—
0—
0−100.00%
38,900,000+710.42%
4,800,000—
0—
0—
0—
0—
0−100.00%
209,900,000−53.30%
449,500,000—
0−100.00%
615,800,000—
0—
0−100.00%
43,500,000—
0—

Frequently asked questions: CGABL common stock issued

What is The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL)'s current common stock issued?

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL)'s latest reported common stock issued (TTM) is $0.00 as of Sep 30, 2026. Cash received from issuing common stock.

How much historical common stock issued data is available for CGABL?

Stock Alarm Pro provides 18 dated annual fiscal periods observations for The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (CGABL)'s common stock issued, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare CGABL's common stock issued to peers or set an alert?

You can open CGABL's common stock issued in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on CGABL delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.